Remove Diabetes Remove Diet Remove Lipid disorders
article thumbnail

Abstract 4145926: The Importance of Dietary Salt in the Process of Atherosclerosis The Results of the International Survey

Circulation

More than 1/3 of the respondents correctly indicated the permissible amount of salt in the diet recommended by WHO; even larger percentage (86.3%) correctly indicated that limiting salt intake in the diet applies to both healthy and sick people. This extremely important mechanism was indicated by only 24% of respondents.

article thumbnail

Creative Alliances in Cardiorenal Metabolic Management: A Game Changer (Part 1) 

Cardiometabolic Health Congress

Cardiometabolic risk encompasses a complex spectrum of interrelated conditions, including cardiovascular disease, type 2 diabetes, and metabolic syndrome. Implementation strategy: Provide training for healthcare providers in motivational interviewing techniques and incorporate these skills into routine patient interactions.

article thumbnail

Cholesterol’s Star Role in Dementia Prevention: New Insights from the 2024 Lancet Dementia Report 

Cardiometabolic Health Congress

Dyslipidemia, characterized by an imbalance in lipids such as cholesterol, LDL-C, triglycerides, and HDL, can result from various factors, including diet, tobacco and alcohol use, a sedentary lifestyle, or genetic conditions like familial hypercholesterolemia.

article thumbnail

FDA Approves Wegovy for Cardiovascular Risk Reduction in Adults with Known Heart Disease and Overweight or Obesity

DAIC

Food and Drug Administration ( FDA ) has approved an additional indication for Wegovy ( semaglutide ) to reduce the risk of major cardiovascular events such as death, heart attack, or stroke in adults with known heart disease and with either obesity or overweight along with a reduced calorie diet and increased physical activity.

Obesity 111